Signaling in rat brainstem via Gpr160 is required for the anorexigenic and antidipsogenic actions of cocaine- and amphetamine-regulated transcript peptide.

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Christopher J HaddockGina L C Yosten

Abstract

Recent work identified Gpr160 as a candidate receptor for cocaine- and amphetamine-regulated transcript peptide (CARTp) and described its role in pain modulation. The aims of the present study were to determine if Gpr160 is required for the CARTp's ability to reduce food intake and water intake and to initially identify the distribution of Gpr160-like immunoreactivity (Gpr160ir) in the rat brain. A passive immunoneutralization approach targeting Gpr160 was used to block the behavioral effects of a pharmacological dose of CARTp in the fourth cerebroventricle (4V) of rats and to determine the importance of endogenously produced CARTp in the control of ingestive behaviors. Passive immunoneutralization of Gpr160 in the 4V blocked the actions of CARTp to inhibit food intake and water intake. Blockade of Gpr160 in the 4V, independent of pharmacological CART treatment, caused an increase in both overnight food intake and water intake. The decrease in food intake, but not water intake, caused by central injection of CARTp was demonstrated to be interrupted by prior administration of a glucagon-like peptide 1 (GLP-1) receptor antagonist. Gpr160ir was observed in several, distinct sites throughout the rat brain, where CARTp staining has ...Continue Reading

References

Jun 3, 1977·Science·Z WiesenfeldD N Tapper
Jun 1, 1978·Pharmacology, Biochemistry, and Behavior·M VijandeB Marin
May 20, 1998·Nature·P KristensenS Hastrup
Jan 30, 1999·The International Journal of Biochemistry & Cell Biology·L ThimB S Wulff
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·L ThimJ T Clausen
Dec 29, 1999·Brain Research·L D AdamsM J Kuhar
Nov 14, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·S AjaT H Moran
Jan 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K YamadaZ Makita
Jul 31, 2002·Neuropeptides·M J KuharB Balkan
Dec 7, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ulrika Smedh, Timothy H Moran
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wing May KongStephen Bloom
Aug 25, 2004·Molecular Psychiatry·G DominguezM J Kuhar
Nov 3, 2004·Trends in Endocrinology and Metabolism : TEM·Richard G HunterMichael J Kuhar
Nov 29, 2005·Peptides·Patrick A KellerFrançoise Assimacopoulos-Jeannet
Jan 10, 2006·Depression and Anxiety·E Miraglia del GiudiceL Perrone
May 16, 2006·Peptides·Aleksandra Vicentic
Jul 11, 2006·Physiology & Behavior·R NorgrenS S Mungarndee
Jan 4, 2007·The Journal of Clinical Investigation·David E Cummings, Joost Overduin
Feb 13, 2007·European Journal of Pharmacology·Lenka MaletínskáBlanka Zelezná
Apr 17, 2007·Brain Research·Richard G HunterBruce S McEwen
May 17, 2008·Regulatory Peptides·Hans-Rudolf Berthoud
May 29, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Karolina P SkibickaHarvey J Grill

❮ Previous
Next ❯

Methods Mentioned

BETA
proximity ligation
transgenic

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.